Emmelot, M.

patient lenalidomide cycle allo-sct maintenance blood treatment fi rst cycle grade myeloma lenalidomide maintenance response cell transplantation erasmus mc trial criteria transplantation frequency study nma allo-sct effect 1 patient therapy figure month analysis disease autologou erasmu 24 cycles allogeneic number terminology criteria center development range article induction research progression hematology signi unmanipulated graft autologous sct incidence day 15 value 2012. lenalidomide treatment netherland nonmyeloablative event ef ficacy library subset survival ficant pfs 1y marrow department follow-up regimen volume hovon increase result september utrecht t cells cd 4ϩ american society myeloma blood graft monique c fi rst-line therapy signi ficant increase nk cells 6 patients table manuscript